Blog
EQS-Adhoc: FRIEDRICH VORWERK grows revenues by 56% to €109 million in the fourth quarter of 2022, but reports a weak EBIT of €2.8 million due to high subcontractor costs
EQS-Adhoc: FRIEDRICH VORWERK grows revenues by 56% to €109 million in the fourth quarter of 2022, but reports a weak EBIT of €2.8 million due to high subcontractor costs
EQS-Adhoc: ATOSS Software AG: ATOSS proposes payout of EUR 2.83 per share
EQS-Adhoc: ATOSS Software AG: ATOSS proposes payout of EUR 2.83 per share
ENERGISME: Chiffre d'affaires 2022 +35%
ENERGISME: Chiffre d'affaires 2022 +35%
EQS-Adhoc: Aldo Kamper will be leaving Leoni AG effective 31 March 2023; the Supervisory Board will be commencing talks immediately on settling his succession
EQS-Adhoc: Aldo Kamper will be leaving Leoni AG effective 31 March 2023; the Supervisory Board will be commencing talks immediately on settling his succession
Kaufman & Broad SA: ANNUAL RESULTS 2022
Kaufman & Broad SA: ANNUAL RESULTS 2022
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Gurit reports net sales of CHF 499.5 million for the calendar year 2022
Gurit reports net sales of CHF 499.5 million for the calendar year 2022
GEVELOT S.A.: Weekly report of share buyback January 30 01 2023
GEVELOT S.A.: Weekly report of share buyback January 30 01 2023
Hardman & Co Research: Q&A with Mark Thomas on Volta Finance Limited (VTA) - Scenario testing showing 20%+ IRR in all likely scenarios
Hardman & Co Research: Q&A with Mark Thomas on Volta Finance Limited (VTA) - Scenario testing showing 20%+ IRR in all likely scenarios
EQS-Adhoc: BAUER Aktiengesellschaft: BAUER AG concludes legal settlement with plaintiffs and plans prompt implementation of capital increase
EQS-Adhoc: BAUER Aktiengesellschaft: BAUER AG concludes legal settlement with plaintiffs and plans prompt implementation of capital increase
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
EQS-News: Francotyp-Postalia Holding AG: Acquisition of treasury shares – 13th interim report
EQS-News: Francotyp-Postalia Holding AG: Acquisition of treasury shares – 13th interim report
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures
EQS-News: Sernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total Thyroidectomy
EQS-News: Sernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total Thyroidectomy
EQS-News: Aurubis AG: Aurubis and Codelco sign an agreement to cooperate on a more sustainable and responsible copper value chain
EQS-News: Aurubis AG: Aurubis and Codelco sign an agreement to cooperate on a more sustainable and responsible copper value chain
EQS-News: SNP SE Increases Revenue and Order Entry in Fiscal Year 2022
EQS-News: SNP SE Increases Revenue and Order Entry in Fiscal Year 2022
Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
EQS-News: CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs
EQS-News: CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)


